Breaking News, Promotions & Moves

Evotec CEO Takes Leave of Absence

Dohrmann, Bond temporarily take over

Dr. Werner Lanthaler, chief executive officer of Evotec, will temporarily stand down from his role due to health reasons. Dr. Cord Dohrmann, chief scientific officer and Colin Bond, chief financial officer, will lead the company in Dr. Lanthaler’s absence.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters